Stay updated with breaking news from Downstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Cell Lysis & Disruption Market Size, Share & Trends Analysis Report by Application (Protein Isolation, Downstream Processing), by...
Lonza has signed a licensing agreement with clinical-stage biopharma, Zhejiang Doer Biologics, whereby the Hangzhou, China based biopharma company will develop multi-specific biotherapeutics using the Swiss CDMO’s XS Pichia.
Moderna and the Australian government have announced an agreement in principle to build a mRNA vaccine manufacturing facility in Victoria, Australia: providing up to 100 million doses a year.
/PRNewswire/ -- The "18th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
/PRNewswire/ -- The "18th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to...